Journal article
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
Abstract
BACKGROUND: The widespread adoption of adjuvant bisphosphonate therapy for postmenopausal early breast cancer (EBC) patients was based on results of the Early Breast Cancer Trialist Group (EBCTCG) meta-analysis. Despite multiple regimens evaluated, there was no signal of varying efficacy with type, dose/dose intensity of bisphosphonate administration. We evaluated the effect of early treatment cessation using long-term outcome data from the …
Authors
Beltran-Bless A-A; Clemons MJ; Fesl C; Greil R; Pond GR; Balic M; Vandermeer L; Bjelic-Radisic V; Singer CF; Steger GG
Journal
European Journal of Cancer, Vol. 180, , pp. 108–116
Publisher
Elsevier
Publication Date
February 2023
DOI
10.1016/j.ejca.2022.12.003
ISSN
0959-8049